← Leaderboards
Lisa M. Privette Vinnedge
Cincinnati Childrens Hosp Med Ctr
$2,960,069
Attributed
$2,960,069
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $698.9K · FY2009–24$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,960,069 · 3
By mechanism
R37$2,516,241 · 1
R01$346,144 · 1
F32$97,684 · 1
Top collaborators
No co-investigators on record.
Most similar at Cincinnati Childrens Hosp Med Ctr
Same institution · by research overlap
- Susanne Irmtraud Wells$12,656,530
- Mohammad Azam$5,839,846
- Biplab Dasgupta$8,405,387
- Gang Huang$4,401,757
- Jose A. Cancelas$9,659,208
Others in their field
Top investigators on “Oncogenic”
- Ralph Parchment · Leidos Biomedical Research, Inc.$141,315,269
- David Heimbrook · Leidos Biomedical Research, Inc.$73,747,183
- Scott W Lowe · Sloan-Kettering Inst Can Research$36,382,798
- John Blenis · Harvard University (Medical School)$29,103,255
- Andrea Califano · Columbia University Health Sciences$28,006,523
- Robert Neil Eisenman · Fred Hutchinson Cancer Research Center$27,166,845
Research focus
OncogenicPathway InteractionsMalignant Breast NeoplasmMalignant NeoplasmsTumorIn VitroTumor GrowthCellsIn VivoMammary GlandProteinsOncogenesOverexpressionProgramsNeoplasticNeoplastic CellKnockout MiceMolecularCancer CellFutureGrowthDek GeneCell Culture TechniquesMouse Model
Grant awards (10)
Mechanisms coupling DEK to oncogenesis$348,787
R37 · FY2024 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$359,801
R37 · FY2023 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$363,713
R37 · FY2022 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$363,713
R37 · FY2021 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$363,713
R37 · FY2020 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$352,801
R37 · FY2019 · CA · contact PI
Exploiting proteotoxic stress in therapy-refractory HER2+ breast cancers$346,144
R01 · FY2019 · CA · contact PI
Mechanisms coupling DEK to oncogenesis$363,713
R37 · FY2018 · CA · contact PI
The role of DEK in breast cancer development and therapy$50,474
F32 · FY2010 · CA · contact PI
The role of DEK in breast cancer development and therapy$47,210
F32 · FY2009 · CA · contact PI